Clinical problems associated with nucleotide metabolism in humans are predominantly the result of abnormal catabolism of the purines. Follow this point on the Clinical Significances of Purine Metabolism. The clinical consequences of abnormal purine metabolism range from mild to severe and even fatal disorders. Clinical manifestations of abnormal purine catabolism arise from the insolubility of the degradation byproduct, uric acid.

Clinical Significances of Purine Metabolism
importance of Purine metabolism

Table of Contents

Clinical Significances of Purine Metabolism

  • Gout is a condition that results from the precipitation of urate as monosodium urate (MSU) or calcium pyrophosphate dihydrate (CPPD) crystals in the synovial fluid of the joints, leading to severe inflammation and arthritis.
  • The inflammatory response is due to the crystals engaging the caspase-1-activating inflammasome resulting in the production of interleukin-1β (IL-1β) and IL-18.
  • Most forms of gout are the result of excess purine production and consequent catabolism or a partial deficiency in the salvage enzyme, HGPRT. Most forms of gout can be treated by administering the antimetabolite: allopurinol.
  • This compound is a structural analogue of hypoxanthine that strongly inhibits xanthine oxidase.
  • Two severe disorders, both quite well described, are associated with defects in purine metabolism: Lesch-Nyhan syndrome and severe combined immunodeficiency disease (SCID). Lesch-Nyhan syndrome results from the loss of a functional HGPRT gene.
  • The disorder is inherited as a sex-linked trait, with the HGPRT gene on the X chromosome (Xq26–q27.2). Patients with this defect exhibit not only severe symptoms of gout but also a severe malfunction of the nervous system. In the most serious cases, patients resort to self-mutilation.
  • Death usually occurs before patients reach their 20th year.
  • SCID is most often (90%) caused by a deficiency in the enzyme adenosine deaminase (ADA). This is the enzyme responsible for converting adenosine to inosine in the catabolism of the purines. This deficiency selectively leads to the destruction of B and T lymphocytes, the cells that mount immune responses.
  • In the absence of ADA, deoxyadenosine is phosphorylated to yield levels of dATP that are 50-fold higher than normal.
  • The levels are especially high in lymphocytes, which have abundant amounts of salvage enzymes, including nucleoside kinases.
  • High concentrations of dATP inhibit ribonucleotide reductase (see below), thereby preventing other dNTPs from being produced.
  • The net effect is to inhibit DNA synthesis. Since lymphocytes must be able to proliferate dramatically in response to antigenic challenges, the inability to synthesize DNA seriously impairs the immune responses, and the disease is usually fatal in infancy unless special protective measures are taken.
  • A less severe immunodeficiency results when there is a lack of purine nucleoside phosphorylase (PNP), another purine-degradative enzyme.
  • One of the many glycogen storage diseases von Gierke disease also leads to excessive uric acid production. This disorder results from a deficiency in glucose 6-phosphatase activity.
  • The increased availability of glucose-6-phosphate increases the rate of flux through the pentose phosphate pathway, yielding an elevation in the level of ribose-5-phosphate and consequently PRPP. The increases in PRPP then result in excess purine biosynthesis.

Similar Posts